News

• New NIH policy reduces number of grant application resubmissions
• ASH mourns the passing of past ASH president Ernest Beutler
• Joint Commission releases sentinel event alert on anticoagulants
• Late-breaking abstracts accepted beginning October 22
• President signs continuing resolution; NIH funded at current level
• The work of Louis K. Diamond and other legends in hematology

Important Dates

October 22 – 29, 2008

Submit late-breaking abstracts online

November 3, 2008

Research Training Award for Fellows letter-of-intent deadline

November 6, 2008

Annual Meeting: Advance registration ends

Blood

First Edition

Archive

• 50th anniversary review: The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga >>
• Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma >>
• Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories >>
• Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma >>
• Seven-year median time to progression with thalidomide for smoldering myeloma >>
• Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid >>